MASTROPASQUA, Mauro Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 3.908
EU - Europa 781
AS - Asia 224
OC - Oceania 5
AF - Africa 2
Totale 4.920
Nazione #
US - Stati Uniti d'America 3.901
SE - Svezia 257
IT - Italia 196
CN - Cina 108
FR - Francia 90
GB - Regno Unito 67
SG - Singapore 38
IN - India 35
DE - Germania 31
UA - Ucraina 27
BE - Belgio 26
FI - Finlandia 21
IR - Iran 13
IE - Irlanda 8
CA - Canada 6
ES - Italia 6
HK - Hong Kong 6
KR - Corea 6
NL - Olanda 6
RO - Romania 6
TR - Turchia 5
HR - Croazia 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
JP - Giappone 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
RU - Federazione Russa 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
ID - Indonesia 1
IL - Israele 1
IS - Islanda 1
LI - Liechtenstein 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 4.920
Città #
Chandler 579
Fairfield 572
Ashburn 306
Woodbridge 277
Houston 262
Seattle 244
Wilmington 219
Nyköping 207
Cambridge 199
Ann Arbor 134
Lawrence 113
Roxbury 92
Des Moines 69
Jacksonville 56
Paris 49
Bari 47
New York 42
San Diego 39
Beijing 34
Princeton 32
Nanjing 27
Brussels 26
Cressa 24
Pune 24
Los Angeles 23
London 22
Falls Church 20
Singapore 20
Inglewood 18
Boardman 15
Dearborn 14
Washington 14
San Mateo 13
Edinburgh 11
Milan 10
Ardabil 9
Leawood 9
Dublin 8
Augusta 7
Hebei 7
Hounslow 7
Amsterdam 6
Hong Kong 6
Fucecchio 5
Grafing 5
Hefei 5
Istanbul 5
Kilburn 5
Madrid 5
Wuhan 5
Brooklyn 4
Changsha 4
Genoa 4
Monmouth Junction 4
Nanchang 4
Taranto 4
Tehran 4
Tianjin 4
Toronto 4
Zagreb 4
Budapest 3
Catania 3
Copenhagen 3
Forlì 3
Frankfurt am Main 3
Munich 3
Naples 3
New Bedfont 3
Santa Clara 3
Scuola 3
Sofia 3
Spoltore 3
Tallinn 3
Tokyo 3
Vienna 3
Acton 2
Atlanta 2
Auckland 2
Barlassina 2
Belgrade 2
Bologna 2
Bucharest 2
Candela 2
Chicago 2
Chiswick 2
Dallas 2
Denver 2
Dubai 2
Florence 2
Guangzhou 2
Gunpo 2
Las Vegas 2
Marcilly-en-Bassigny 2
Marseille 2
Mascalucia 2
Modugno 2
Montreal 2
Mumbai 2
Norwalk 2
Orzivecchi 2
Totale 4.082
Nome #
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss working group of breast- and gynecopathologists 171
Analytical validation of a standardized scoring protocol for Ki67: Phase 3 of an international multicenter collaboration 138
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer 117
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 105
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 96
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 93
null 88
Tumore a Cellule del Sertoli a Grandi Cellule Calcificante (TCSGCC) ad evoluzione maligna. Studio di un caso. 86
Adenomyoepithelioma 73
Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies 70
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 66
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy 64
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial 64
null 59
Mammary stereotaxic core-biopsy by Mammotome: an alternative to frozen section examination 57
null 57
BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM 57
Basaloid cell carcinoma of the prostate. Case report and review of the literature 56
Regulation of mRNA and protein levels of beta 1 integrin variants in human prostate carcinoma 55
Malignant Large Cell Calcifying Sertoli Cell Tumor of the Testis (LCCSCTT). Report of a case in an elderly man and review of the literature 55
A new technique for foetal brain fixation and extraction 55
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression 54
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer 53
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression 52
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology 51
Abstract S4-6: An international Ki67 reproducibility study 51
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer 51
Peri-Prostatic Epidermal Inclusion Cyst: A Case Report 50
null 49
Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series 49
Microbiopsia mammaria stereotassica. 48
Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies 48
Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report 47
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy 47
Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases 47
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study 47
Abstract P5-07-02: Systematic analysis and modulation of Ki67 interobserver variance in 9069 patients from three clinical trials – How much pathologist concordance is needed for meaningful biomarker results? 46
Mesotelioma multicistico benigno del pericardio. Descrizione di un caso 45
Abstract P1-15-06: Lobular histology and partial breast irradiation: To what extent is it a cautionary parameter? 45
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer 45
Breast cancer subtypes and outcome after local and regional relapse 44
Outcome of special types of luminal breast cancer 44
Primary and secondary angiosarcomas of the breast: A single institution experience 44
Accelerated partial breast irradiation with intraoperative electrons: Using GEC-ESTRO recommendations as guidance for patient selection 44
Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast 43
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer 43
Metastatic tumors of the oro-facial tissues: Clear cell renal cell carcinoma. A clinico-pathological study of seven cases 43
Benign multicystic mesothelioma of the pericardium (BMMP). A case report 42
Testicular Modification Induced by Low Alcohol Intake in Rat. Morphometric Investigations and bcl-2 Oncogene Expression 42
Progesterone receptor loss identifies luminal B breast cancer subgroups at higher risk of relapse 42
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial 42
Angiomixoma aggressivo dello scroto. Studio di un caso 42
Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know 42
Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome 41
An international study to increase concordance in Ki67 scoring 41
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes 41
Male breast cancer 41
null 40
Positive axillary sentinel lymph node: Is axillary dissection always necessary? 40
Outcome and medial presentation of breast cancer: European Institute of Oncology experience 40
Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration 40
Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: Current and resolving controversies on the basis of the European Institute of Oncology experience 40
Prognostic significance of Ki-67 in node-negative (pN0), triple-negative (TN) breast cancer (BC) 40
Mechanical characterization of human urethra 40
Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast 40
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 39
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy 39
HER2-negative (1+) breast cancer with unfavorable prognostic features: To FISH or not to FISH? 39
Paget's disease as a local recurrence after nipple-sparing mastectomy: Clinical presentation, treatment, outcome, and risk factor analysis 39
Pathological complete response after preoperative systemic therapy and outcome: Relevance of clinical and biologic baseline features 38
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 38
Calcified metastatic mediastinal lymph nodes from mucinous breast adenocarcinoma 38
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration 38
What can the pathologist offer for optimal treatment choice? 38
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer 37
Breast cancer pathology 37
Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration 36
Robotic vs open prostatectomy in a laparoscopically naive centre: A matched-pair analysis 36
Breast cancer subtypes and outcome after local and regional relapse 36
Studio delle regioni organizzatrici argirofile del nucleolo (AgNORs) nelle neoformazioni colo-rettali quale indice di malignità biologica. [Argyrophilic nucleolar organizer regions (AgNORs) as malignancy biomarkers in colorectal neoplasms]. 35
Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer 35
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution 35
Immunotherapy Bridge 2020 and Melanoma Bridge 2020: meeting abstracts Characterization of the metastatic behaviour and gene expres‐ sion profile (RNAseq) of different melanoma cell lines: a compre‐ hensive in vivo model. 35
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation 35
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 34
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial 34
Atypical vascular lesions after radiation therapy for breast cancer: A clinicopathologic study and outcomes of 24 cases 33
An international ki67 reproducibility study 33
Diagnostic and therapeutic management of carcinoma of unknown primary: Histopathological and molecular diagnosis 32
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 32
The prognostic role of high Ki-67 in early breast cancer patients who do not receive axillary dissection or axillary radiotherapy 31
Wireless ultrasound-guided vacuum-assisted breast biopsy: Experience in clinical practice at European Institute of Oncology 31
Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons 30
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate? 30
Predicting the risk of additional axillary metastases in patients with breast carcinoma and positive sentinel node biopsy. A study of 1228 patients treated in a single institution including 116 patients with isolated tumor cells only in the sentinel lymph nodes 29
LOCOREGIONAL RECURRENCE AFTER CONSERVATIVE SURGERY FOR DUCTAL BREAST CANCER: ROLE OF SURGICAL MARGIN 29
Occasional finding of a carcinoid in a vermiform appendix-like structure inside a mature cystic teratoma of the ovary 29
null 28
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer 28
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy 27
Totale 4.841
Categoria #
all - tutte 31.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020776 0 22 7 43 37 35 37 37 42 220 138 158
2020/20211.420 138 254 150 170 52 30 59 149 45 158 82 133
2021/2022699 36 25 1 19 57 111 13 36 42 95 52 212
2022/20231.473 155 149 92 147 105 191 54 234 207 20 95 24
2023/2024540 41 85 34 24 51 127 25 46 3 14 35 55
2024/202548 23 25 0 0 0 0 0 0 0 0 0 0
Totale 5.303